Lixte Biotechnology Holdings Inc (LIXT)

Form 8-K - Current report

A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch

Issued on behalf of LIXTE Biotechnology Holdings, Inc. Having entered into definitive documents to combine with...

The AI Boom’s Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It

Issued on behalf of LIXTE Biotechnology Holdings, Inc. Having entered into definitive documents to combine with...

LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026

Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined...

Form 8-K - Current report

The New Bottleneck Isn’t Computing Power — It’s Just Power

Issued on behalf of LIXTE Biotechnology Holdings, Inc. America can build data centers in months, but the...

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch PR Newswire BOCA RATON, Fla...

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS •...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report